Critics said it was concerning that full approval was based on only six months’ worth of data — despite clinical trials designed for two years — and that there was no public discussion of the data.
U.S. drug regulators on Monday approved the COVID-19 vaccine from Pfizer and BioNTech for people 16 and older, making it the first such shot to receive approval in the country.
Houston hospitals have “reached a breaking point” amid a COVID-19 outbreak, which struck weeks after 150 hospital workers were fired by Houston Methodist hospital, one of several hospitals struggling.
A conservative digital media company’s focus on the culture wars in America appears to be paying off, as it is the fastest-growing private advertising and marketing business in the U.S., according to the 2021 Inc. 5000 list released Tuesday.
The U.S. Defense Advanced Research Projects Agency (DARPA) awarded the gene-based vaccine developer $25.3 million "to research and develop its messenger RNA therapeutics" nearly 8 years ago.